会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 13. 发明授权
    • Polypeptide hormones of the thymus
    • 多肽激素的胸腺
    • US4077949A
    • 1978-03-07
    • US606843
    • 1975-08-22
    • Gideon Goldstein
    • Gideon Goldstein
    • A61K38/00C07K14/66C07C103/52A61K37/00
    • C07K14/66A61K38/00Y10S530/854Y10S930/18
    • There are disclosed closely related new polypeptides isolated from bovine thymus, which are distinct polypeptides denoted as Thymin I and Thymin II or Thymopoietin I and Thymopoietin II, respectively. Thymin I may be characterized as having a relative mobility (Rf) on 7% polyacrylamide gel disc electrophoresis of 0.63 with respect to methyl green at a pH of 4.3, and having the following structural sequence:H.sub.2 n-gly-gln-phe-leu-glu-asp-pro-ser-val-leu-thr-lys-glu-lys-leu-lys-ser-glu-leu-val-ala-asn-asn-val-thr-leu-pro-ala-gly-glu-gln-arg-lys-asp-val-tyr-val-gln-leu-tyr-leu-gln-his-leu-thr-ala-val-lys-arg-cooh.Thymin II may be characterized as having a relative mobility (Rf) on 7% polyacrylamide gel disc electrophoresis of 0.57 with respect to methyl green at a pH of 4.3, and having the following structural sequence:H.sub.2 n-ser-gln-phe-leu-glu-asp-pro-ser-val-leu-thr-lys-glu-lys-leu-lys-ser-glu-leu-val-ala-asn-val-thr-leu-pro-ala-gly-glu-gln-arg-lys-asp-val-tyr-val-gln-leu-tyr-leu-gln-thr-leu-thr-ala-val-lys-arg-cooh.Both polypeptides are highly purified and in powder form and are isolated from bovine thymus by multiple purification methods involving molecular sieving and chromatography. Both products cause delayed impairment of neuromuscular transmission in vivo and induce bone marrow cells to develop the characteristics of thymus-derived lymphocytes and thus are useful in therapeutic areas involving thymic or immunity deficiencies or imbalances, and neuromuscular hyperactivity.
    • 公开了分离自牛胸腺的密切相关的新多肽,其分别是分别称为Thymin I和Thymin II或Thymopoietin I和Thymopoietin II的不同多肽。 可以将Thymin I的特征在于在4.3的pH下,相对于甲基绿在7%聚丙烯酰胺凝胶盘电泳上具有0.63的相对迁移率(Rf),并且具有以下结构序列:
    • 15. 发明申请
    • Compositions and methods for the treatment and prophylaxis of Alzheimer's disease
    • 用于治疗和预防阿尔茨海默病的组合物和方法
    • US20090123488A1
    • 2009-05-14
    • US11891880
    • 2007-08-14
    • Gideon Goldstein
    • Gideon Goldstein
    • A61K39/385A61P37/04
    • A61K45/06A61K31/714A61K2300/00
    • A self-adjuvanting immunogenic composition comprising an immunogen comprising a lipopeptide cap (R2), a universal T helper sequence (R1) and an immunodominant Aβ B cell epitope. The immunogen also comprises one or more linker sequences and/or polar charged amino acid sequences. The B cell epitope of each immunogen has an amino acid sequence located within the first 17 amino acids of SEQ ID NO: 1. The lipopeptide is a dipalmitoyl-S-glyceryl-cysteine or a tripalmitoyl-S-glyceryl cysteine or N-acetyl (dipalmitoyl-S-glyceryl cysteine), each with an optional neutral amino acid linker. Optional polar sequences of at least four charged polar amino acids enhance solubility of the immunogen and are located at the carboxy terminal end of R2, optionally flanked by neutral linker amino acids, or elsewhere in the immunogen. Such compositions, at surprisingly low dosages of less than 10 mg per subject, can induce anti-Aβ peptide antibodies with GMTs of 50,000 or greater than 1,000,000 when employed to immunize a mammalian subject, without any extrinsic adjuvant.
    • 一种自佐剂免疫原性组合物,其包含包含脂肽帽(R2),通用T辅助序列(R1)和免疫优势Abeta B细胞表位的免疫原。 免疫原还包含一个或多个接头序列和/或极性带电荷的氨基酸序列。 每个免疫原的B细胞表位具有位于SEQ ID NO:1的前17个氨基酸内的氨基酸序列。脂肽是二棕榈酰基-S-甘油基半胱氨酸或三棕榈酰基-S-甘油基半胱氨酸或N-乙酰基( 二棕榈酰基-S-甘油基半胱氨酸),每个具有任选的中性氨基酸接头。 至少四个带电极性氨基酸的任选的极性序列增强了免疫原的溶解度,并且位于R2的羧基末端,任选地侧接于中性接头氨基酸或免疫原中的其他位置。 当以惊人的低剂量小于10mg每个受试者时,这些组合物可以诱导具有50,000或大于1,000,000的GMT的抗Aβ肽抗体,当用于免疫哺乳动物受试者时,没有任何外源性佐剂。